Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
923 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
3 Recruiting Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Bronchial Neoplasms;   Carcinoma, Bronchogenic;   Lung Diseases;   Lung Neoplasms
Intervention:
4 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
5 Not yet recruiting International Lung Screen Trial (ILST)
Conditions: Non-small Cell Lung Cancer;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Smokers at Risk of Lung Cancer
Intervention: Radiation: Low dose CT
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
8 Recruiting Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Patient Reported Outcomes
9 Not yet recruiting A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
Conditions: ALK-positive Non-small Cell Lung Cancer (NSCLC);   RET-positive Non-small Cell Lung Cancer (NSCLC);   RET-positive Thyroid Cancer
Intervention: Drug: Alectinib
10 Recruiting Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Biological: AdV-tk (aglatimagene besadenovec) + valacyclovir
11 Recruiting Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC.
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: PLB1003
12 Not yet recruiting To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC
Conditions: NSCLC Stage IV;   NSCLC, Stage III
Interventions: Dietary Supplement: Oligo Fucoidan;   Dietary Supplement: Placebo
13 Not yet recruiting Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Durvalumab;   Drug: Tremelimumab
14 Recruiting A Study of the Correlation Between Cancer-related Fatigue, Survival and Physiological Factors in Non-Small Cell Lung Cancer (NSCLC) Patients Under Chemotherapy
Condition: Non-small Cell Lung Cancer
Intervention:
15 Recruiting The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer
Condition: Apatinib in Maintenance Treatment
Intervention: Drug: Apatinib
16 Recruiting An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Apatinib Mesylate tablet combined with S-1 capsules
17 Not yet recruiting Locally Advanced NSCLC Hyperfractionated RT
Condition: Carcinoma, Non Small Cell Lung (NSCLC)
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Daily hyperfractionated radiation therapy
18 Not yet recruiting AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Condition: Advanced NSCLC
Intervention: Drug: Alflutinib
19 Not yet recruiting A Study of Apatinib Plus Docetaxel for Treatment of Advanced EGFR Wild Type Non-squamous Non-small Cell Lung Cancer With Bone Metastases
Condition: Non-squamous Non-small Cell Lung Cancer
Interventions: Drug: apatinib docetaxel zoledronic;   Drug: docetaxel zoledronic
20 Recruiting A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)
Condition: EGFR Positive Non-small Cell Lung Cancer
Interventions: Drug: Erlotinib plus Bevacizumab;   Drug: Erlotinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.